论文部分内容阅读
本试验组检测５７例心脑梗塞患者、５５例正常健康中老年人血清ＬＰ（ａ）、ＡｐｏＡＩ、ＡｐｏＢ浓度及ＡｐｏＡＩ／ＡｐｏＢ比值，统计学分析显示：这些指标及其异常检出率是心脑血管疾病的有效检测指示；随访检测发现ＡｐｏＡＩ、Ｂ浓度及ＡｐｏＡＩ／ＡｐｏＢ比值随病情变化而波动，可作为心脑血管疾病疗效的监测指标；Ｌｐ（ａ）浓度不受年龄、健康状况及一般降脂药物影响，是预测心脑血管疾病风险度的独立危险因素。
The experimental group detected serum LP (a), ApoAI, ApoB and ApoAI / ApoB ratio in 57 patients with myocardial infarction and 55 healthy controls. Statistical analysis showed that these indicators and the abnormal detection rate were cardiac Follow-up test found that the ApoAI, B concentration and ApoAI / ApoB ratio fluctuations with the changes in the disease can be used as indicators of cardiovascular and cerebrovascular disease efficacy monitoring; Lp (a) concentration from age, health and general decline Lipid drug effects, is an independent risk factor for predicting the risk of cardiovascular and cerebrovascular diseases.